CN110859895A - Eye ointment and preparation method thereof - Google Patents
Eye ointment and preparation method thereof Download PDFInfo
- Publication number
- CN110859895A CN110859895A CN201911281566.5A CN201911281566A CN110859895A CN 110859895 A CN110859895 A CN 110859895A CN 201911281566 A CN201911281566 A CN 201911281566A CN 110859895 A CN110859895 A CN 110859895A
- Authority
- CN
- China
- Prior art keywords
- eye ointment
- lanolin
- eye
- menthol
- essential oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Marine Sciences & Fisheries (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides an eye ointment and a preparation method thereof, the raw materials comprise medicinal materials and a substrate, and the medicinal materials comprise cassia seed, chrysanthemum, pearl powder, musk, calamine, menthol, borneol, saffron and jasmine essential oil; the matrix comprises lanolin and yellow vaseline; the weight ratio of the raw materials is cassia seed: chrysanthemum: pearl powder: musk: calamine: menthol: borneol: saffron: and (3) jasmine essential oil: lanolin: yellow petrolatum = 20-50: 20-50: 15-30: 5-8: 30-60: 3-5: 1-2: 10-15: 5-10: 100-250: 250-500. The eye ointment provided by the invention can be strongly permeated through related acupuncture points around the eyes, so that the microcirculation of the eyes is improved, the blood flow is increased, the visual excitement is improved, the visual threshold is reduced, the trace elements required by the eyes are effectively supplemented, the elasticity of ciliary muscles is recovered, the vision is fundamentally recovered, and the relapse is avoided.
Description
Technical Field
The invention relates to an eye ointment; the invention also relates to a preparation method of the eye ointment.
Background
Eye diseases are commonly called by various eye diseases, modern western medicine subdivides the eye diseases into common eye diseases such as keratitis, iritis, red and red swelling, dryness, fundus congestion, night blindness and the like, and the western medicine mostly adopts treatment modes such as external preparations (such as eye drops, eye gel, eye ointment and the like), operations and the like, which often affect the eye use or the face beauty of patients and have side effects. For hemorrhagic ophthalmopathy and difficult and chronic ophthalmopathy, the treatment effect is poor, the radical treatment rate is low, and the disease is easy to relapse. After western medicines or operation treatment are taken for a long time, many patients with eye diseases have symptoms such as dizziness, shortness of breath, laziness in speaking, lassitude, weakness, abdominal fullness and distention, spontaneous perspiration, night sweat, insomnia, dreaminess, five-heart fever and the like, while western medicines generally do not have positive changes, and the most important aspect of the traditional Chinese medicine is to pay special attention to the relationship between eyes and viscera, meridians, qi, blood and body fluid when treating the eye diseases. In the theory of Ling Shu and Da Huo, the essence-qi of five zang-organs and six fu-organs is the essence that is injected into the eyes. The nest of essence is the eye, the essence of bone is the pupil, the essence of tendon is the black eye, the essence of blood is the collaterals, the essence of nest qi is the white eye, the essence of muscle is the restriction, and wraps up the essence of blood and qi of tendons and bones, and the blood vessel is the system, which belongs to the brain and then comes out of the neck. The meridians and collaterals are the functions of circulating qi and blood throughout the body and communicating the exterior, interior and exterior, and connecting the zang-fu organs. In Ling Shu and the chapter of visceral diseases, the blood and qi flow through the twelve main meridians and the three hundred six fifteen collaterals, the essence and yang flow through the eyes and are the essence. All this means that the eyes and zang-fu organs are connected and communicated by meridians and collaterals, and they are in organic connection. The visual function of the eyes is maintained only by continuously delivering the air and blood to the meridian points of the eyes.
Clinical research shows that the pathogenesis of myopia mainly comprises two aspects in the dialectical theory of traditional Chinese medicine, on one hand, the symptoms of visual acuity, long-term vision and blood and qi impairment are used, so that the nerve light in the eyes can not be beyond the distance; on the other hand, the symptoms are liver and kidney deficiency, congenital deficiency, neurasthenia, and shortsightedness. Therefore, the meridians and collaterals, the five zang-organs and the six fu-organs of the human body are communicated with the eyes, and the normal functions of the eyes are maintained by continuously transmitting qi and blood through the meridians and collaterals.
At present, the shortsightedness population of China exceeds 4.5 hundred million, and nearly one of every three people is the shortsightedness. Wherein, the serious-disaster area of myopia is the age range of teenagers of 10-18 years old, the incidence rate of myopia of the teenagers in China surpasses that of the other countries, and the myopia is the first to live in the world. The defective vision rates of the students in small, early, high and big countries are 45.71%, 74.36%, 83.28% and 86.36%, respectively. In the existing eye ointment for treating myopia, a part of the eye ointment must be applied into eyes, so that the eye ointment is inconvenient to use and easily causes secondary infection such as keratitis and the like; the topical eye ointment is applied to the outside of the eye, does not directly contact with eye mucous membrane tissues and eyeball organs, and has poor penetration and absorption, so the treatment effect is poor.
Disclosure of Invention
The invention aims to provide an eye ointment, which solves the problem of poor treatment effect of the existing external eye ointment.
The second purpose of the invention is to provide a preparation method of the eye ointment.
The technical scheme provided by the invention is as follows:
an eye ointment is prepared from raw materials and matrix, wherein the raw materials include semen Cassiae, flos Chrysanthemi, Margarita powder, Moschus, Galamina, Mentholum, Borneolum Syntheticum, stigma croci Sativi and flos Jasmini sambac essential oil; the matrix comprises lanolin and yellow vaseline; the weight ratio of the raw materials is cassia seed: chrysanthemum: pearl powder: musk: calamine: menthol: borneol: saffron: and (3) jasmine essential oil: lanolin: yellow petrolatum = 20-50: 20-50: 15-30: 5-8: 30-60: 3-5: 1-2: 10-15: 5-10: 100-250: 250-500.
The preparation method of the eye ointment comprises the following steps:
A. removing impurities from semen Cassiae, flos Chrysanthemi, Margarita powder, Moschus, Galamina, and stigma croci Sativi, oven drying, pulverizing semen Cassiae, flos Chrysanthemi, Galamina, and stigma croci Sativi, wrapping with gauze to form medicated bag, and pulverizing Moschus separately;
B. soaking the medicated bag in water, decocting, and collecting the supernatant;
C. heating yellow vaseline and lanolin in a container, melting, filtering, and sterilizing to obtain matrix.
D. Dissolving Mentholum and radix Gentianae with ethanol, adding dissolved Mentholum and radix Gentianae into matrix, and mixing.
E. Adding Moschus, Margarita powder, flos Jasmini sambac essential oil and supernatant into the matrix in sequence, and mixing.
The medicinal materials used in the invention have the following properties and effects:
cassia seed: cold in nature, sweet and bitter in taste. It can clear heat and improve vision, and can treat conjunctival congestion, pain and photophobia with lacrimation.
Chrysanthemum: cold in nature, sweet and bitter in taste. It can pacify liver and improve vision, and can be used for treating conjunctival congestion, swelling and pain, and blurred vision. Pearl powder: cold in nature, sweet and salty in flavor. Tranquilizing, arresting convulsion, improving eyesight, removing nebula, removing toxic substance, and promoting granulation.
Musk: warm in nature and pungent in flavor. Pungent and fragrant smell can induce resuscitation and avoid dirt, remove toxicity and dissipate blood stasis to remove nebula.
Saffron: sweet in nature and mild in nature. Promoting blood circulation, removing blood stasis, dredging channels and relieving pain.
Calamine: mild in nature and sweet in taste. Detoxicating, improving eyesight, removing nebula, astringing dampness, relieving itching, and healing sore.
And (3) jasmine essential oil: the essence is called as king of essential oil, has elegant smell, is aromatic, striking and refreshing, improves the dryness, water and oil shortage and sensitivity of skin, promotes blood circulation and removes meridian obstruction, and has obvious effects on human bodies of biological components such as jasmone, geraniol and the like.
Menthol: has pungent and cool taste, and has effects of dispelling pathogenic wind, clearing heat, improving eyesight, and removing toxic substance.
Borneol: slightly cold in nature and pungent in flavor, and can induce resuscitation, refresh mind, dispel stagnated fire, remove nebula and improve vision.
1. The calamine and saffron crocus used in the eye ointment provided by the invention have the functions of tonifying and changing liver, strengthening spleen and replenishing qi, promoting blood circulation and removing obstruction in channels, inducing resuscitation and improving eyesight and the like, and the increase of the blood flow of the eyes of a patient is ensured; the eye ointment contains Moschus and Margarita powder as rare medicinal materials, and can penetrate into skin and acupoints to relieve ciliary spasm through each vein of eye; the jasmine essential oil in the eye ointment has the medicinal efficacy of refreshing and striking eyes, and also has the efficacy of guiding drugs and medicinal material soakage agents, so that the effective utilization rate and the permeability of the medicinal materials are improved; the synergistic effect of the medicines is helpful for recovering the elasticity and the autonomous adjusting capability of the eyeballs, gradually shortens the axle distance of the eyeballs and has obvious effect on treating myopia.
2. According to the eye ointment provided by the invention, calamine is used as a monarch drug, cassia seed and saffron are used as ministerial drugs, pearl powder is used as an adjuvant drug, gentian and musk are led, natural jasmine essential oil is matched for aromatic permeation, and a specific proportion and a using method are adopted, so that the eye ointment can be strongly permeated through related acupuncture points around eyes, thereby improving eye microcirculation, increasing blood flow, improving visual excitement, reducing visual threshold and effectively supplementing trace elements required by the eyes; meanwhile, the eye drops can permeate into the eyeground through various acupuncture points of the eyes and the skin of the eyes, have the effects of strengthening the spleen and stomach, nourishing yin and tonifying the kidney, generating blood and replenishing essence, and reinforcing primordial qi, promote the metabolism of 'cornea crystalline lens', recover the elasticity of ciliary muscles, fundamentally recover the vision and avoid relapse.
3. The eye ointment provided by the invention has the advantages of few raw material types, simple preparation process, low cost, natural safety and no toxic or side effect on human bodies.
Detailed Description
The technical solution provided by the present invention is described in more detail with reference to the following specific embodiments.
Example 1
An eye ointment is prepared from semen Cassiae, flos Chrysanthemi, Margarita powder, Moschus, Galamina, Mentholum, Borneolum Syntheticum, stigma croci Sativi and flos Jasmini sambac essential oil; the matrix comprises lanolin and yellow vaseline. The weight ratio of the raw materials is cassia seed: chrysanthemum: pearl powder: musk: calamine: menthol: borneol: saffron and jasmine essential oil: lanolin: yellow petrolatum = 30: 30: 20: 5: 50: 5: 1: 10: 5: 100: 250.
the preparation method of the eye ointment comprises the following steps:
A. removing impurities from cassia seed, chrysanthemum, pearl powder, musk, calamine and saffron crocus respectively and drying the cassia seed, the chrysanthemum, the pearl powder, the musk, the calamine and the saffron crocus respectively, wherein the cassia seed, the chrysanthemum, the pearl powder, the musk, the calamine and the saffron crocus are determined to be 3 kg of cassia seed, 3 kg of chrysanthemum, 2 kg of pearl powder, 500 g of musk, 5 kg of calamine, 500 g of menthol, 100 g of borneol, 1 kg of saffron croc; mixing semen Cassiae, flos Chrysanthemi, Galamina, and stigma croci Sativi, pulverizing, sieving with 120 mesh sieve, collecting undersize, and tightly wrapping with 4 layers of gauze to form medicated bag; pulverizing Moschus separately, sieving with 120 mesh sieve, and collecting the sieved material.
B. Soaking the medicine bag in 24 kg of water for 10 min, decocting for 60 min, taking out the medicine bag, precipitating the medicine liquid, filtering with gauze, and collecting the supernatant for later use.
C. Placing yellow vaseline and lanolin in stainless steel container, heating to 70 deg.C, melting completely, filtering with 120 mesh sieve, pouring the filtrate into stainless steel container, capping, heating to 160 deg.C, sterilizing, and maintaining for 1 hr to obtain matrix.
D. Dissolving Mentholum and radix Gentianae with ethanol, cooling to 50 deg.C, adding dissolved Mentholum and radix Gentianae into the matrix, and stirring with Japanese pagodatree stick;
E. adding Moschus into the matrix, stirring with a locust stick, adding Margarita powder, stirring with a locust stick, adding flos Jasmini sambac essential oil, stirring with a locust stick, mixing, pouring the supernatant, stirring with a locust stick for 2000 times clockwise, stirring counterclockwise for 2000 times to obtain eye ointment, and canning, wherein the dosage of one can is 10 g.
Example 2:
an eye ointment comprises medicinal materials and matrix, wherein the medicinal materials comprise semen Cassiae, flos Chrysanthemi, Margarita powder, Moschus, Galamina, Mentholum, Borneolum Syntheticum, stigma croci Sativi and flos Jasmini sambac essential oil; the matrix comprises lanolin and yellow vaseline. The weight ratio of the raw materials is cassia seed: chrysanthemum: pearl powder: musk: calamine: menthol: borneol: saffron and jasmine essential oil: lanolin: yellow petrolatum = 50: 20: 30: 6: 60: 3: 2: 15: 10: 250: 500.
the preparation method of the eye ointment comprises the following steps:
A. 5 kg of semen cassiae, 2 kg of chrysanthemum, 3 kg of pearl powder, 600 g of musk, 6 kg of calamine, 300 g of menthol, 200 g of borneol, 1.5 kg of saffron, 1 kg of jasmine essential oil, 25 kg of lanolin and 50 kg of yellow vaseline. Removing impurities from semen Cassiae, flos Chrysanthemi, Margarita powder, Moschus, Galamina, and stigma croci Sativi, respectively, and oven drying; mixing semen Cassiae, flos Chrysanthemi, Galamina, and stigma croci Sativi, pulverizing, sieving with 120 mesh sieve, collecting undersize, and tightly wrapping with 4 layers of gauze to form medicated bag; pulverizing Moschus separately, sieving with 120 mesh sieve, and collecting the sieved material.
B. Soaking the medicine bag in 29 kg of water for 15 minutes, decocting for 30 minutes, taking out the medicine bag, precipitating the medicine liquid, filtering with gauze, and taking the supernatant for later use.
C. Placing yellow vaseline and lanolin in stainless steel container, heating to 80 deg.C, melting completely, filtering with 150 mesh sieve, pouring the filtrate into stainless steel container, capping, heating to 160 deg.C, sterilizing, and maintaining for 1 hr to obtain matrix.
D. Dissolving Mentholum and radix Gentianae with ethanol, cooling to 50 deg.C, adding into yellow vaseline and lanolin, and stirring with ramulus Salicis Babylonicae.
E. Adding Moschus into the matrix, stirring with ramulus Salicis Babylonicae, adding Margarita powder, stirring with ramulus Salicis Babylonicae, adding flos Jasmini sambac essential oil, and mixing with ramulus Salicis Babylonicae; finally, the supernatant is poured into the substrate, willow branches are stirred for 2000 times clockwise, and then 2000 times anticlockwise to obtain the eye ointment, and the eye ointment is canned, wherein the dosage of one pot is 15 g.
Example 3:
an eye ointment comprises medicinal materials and matrix, wherein the medicinal materials comprise semen Cassiae, flos Chrysanthemi, Margarita powder, Moschus, Galamina, Mentholum, Borneolum Syntheticum, stigma croci Sativi and flos Jasmini sambac essential oil; the matrix comprises lanolin and yellow vaseline. The weight ratio of the raw materials is cassia seed: chrysanthemum: pearl powder: musk: calamine: menthol: borneol: saffron and jasmine essential oil: lanolin: yellow petrolatum = 20: 50: 15: 8: 30: 4: 1.5: 13: 7: 200: 350.
the preparation method of the eye ointment comprises the following steps:
A. 2 kg of semen cassiae, 5 kg of chrysanthemum, 1.5 kg of pearl powder, 800 g of musk, 3 kg of calamine, 400 g of menthol, 150 g of borneol, 1.3 kg of saffron crocus, 700 g of jasmine essential oil, 20 kg of lanolin and 35 kg of yellow vaseline. Removing impurities from semen Cassiae, flos Chrysanthemi, Margarita powder, Moschus, Galamina, and stigma croci Sativi, respectively, and oven drying; mixing semen Cassiae, flos Chrysanthemi, Galamina, and stigma croci Sativi, pulverizing, sieving with 120 mesh sieve, collecting undersize, and tightly wrapping with 4 layers of gauze to form medicated bag; pulverizing Moschus separately, sieving with 120 mesh sieve, and collecting the sieved material.
B. Soaking the medicine bag in 22.6 kg of water for 12 min, decocting for 45 min, taking out the medicine bag, precipitating the medicine liquid, filtering with gauze, and collecting the supernatant for use.
C. Placing yellow vaseline and lanolin in stainless steel container, heating to 70 deg.C, melting completely, filtering with 140 mesh sieve, pouring the filtrate into stainless steel container, capping, heating to 160 deg.C, sterilizing, and maintaining for 1 hr to obtain matrix.
D. Dissolving Mentholum and radix Gentianae with ethanol, adding dissolved Mentholum and radix Gentianae into matrix, and stirring with ramulus Salicis Babylonicae.
E. Adding musk into the matrix, uniformly stirring with willow branches, adding pearl powder, uniformly stirring with willow branches, then adding jasmine essential oil, mixing with willow branches, stirring and blending, finally pouring the supernatant, stirring with willow branches for 2000 times clockwise, then stirring for 2000 times anticlockwise to obtain the eye ointment, canning, and filling 10 g of the eye ointment in one can.
The application method of the eye ointment provided by the invention is external application massage, and the specific application method is as follows:
taking about 1.0g of eye ointment, closing eyes, uniformly coating the eye ointment on the periphery of two eyes (not entering the eyes) and related acupuncture points around the eyes, gently massaging with fingers for about 10 minutes, gently massaging from the Jingming acupuncture point to the tail of the eyes from the lower part of the eyes, then gently massaging from the upper part of the eyes from inside to outside for 4-5 times a day, and continuously using for 20 days as a treatment course.
The prescription is used for teenager myopia patients in the Eggery and the national center of vision
The comparison test is carried out on the patient with the eye ointment and the patient who only does the eye exercises, and the test conditions are as follows:
the test subject is myopia of middle and primary school students with age of 6-15 years. The observation group uses the eye ointment, totally 160 people, 320 eyes, 2 times per day, each time uses the eye ointment and cooperates with the eyes to massage for 10 minutes to 15 minutes, 20 days is a treatment course, and the test period is two treatment courses. The two treatment courses are uninterrupted. The control group was operated with eye exercises only for 80 persons and 160 eyes for a total, and the test period was 40 days. The results of the tests are shown in table 1 below:
TABLE 1 comparative test results
The test results show that compared with the eye exercises, the eye ointment of the invention has the advantages of treating the eye diseases closely
Has obvious curative effect on ophthalmopathy.
The clinical experimental conditions of the eye ointment of the invention on various eye diseases are as follows:
yangming, male, Shaanxi xi' an people, high myopia when students are 35 years old and 16 years old, wearing glasses, applying the eye ointment after 20 years old graduates for 20 days, wiping eyes for 20 days, and taking off the glasses, wherein the eyes are close to normal vision, and the diseases do not recur in 15 years, thereby achieving the clinical healing effect.
ChengShi, male, Shanxi Cuchuan people, 80 years old, 49 years old are the eyes, the eye ointment of the invention is used for treating for 18 days, the binocular vision returns to normal, the glasses are taken off, and the disease does not recur in 31 years.
The chivalrous swordsman, the woman and the Shaanxi Yao state people are 65 years old, the people can see things beyond 10 meters in a fuzzy way, the people can normally live only by wearing presbyopic glasses, the multi-party treatment effect is not obvious in all hospitals, the eye ointment is used for smearing the periphery of the eyes, the things beyond 25 meters can be clearly seen after being matched with acupuncture point massage for 15 days, the people can normally live without wearing presbyopic glasses after one month, and the recurrence is not seen until now.
The European prickly ash peel plum, women, Beijing people, 57 years old, suffered from cataract before 3 years old, and the right eyeball suffered from severe oppression, swelling and pain, double images and nausea when seeing things, and early cataract detected in hospitals, always depends on drug control, and the treatment is not good repeatedly and the seeing things are more and more unclear. The eye ointment of the invention is used for 10 days, the feeling of eye swelling pain is relieved; after the eye care product is used for one month, the eye swelling and pain feeling disappears, the vision is basically recovered after the eye care product is used for half a year, and the problems of housework and television watching do not occur.
Smiling in Wen, Shanxi Han Zhong, female, 32 years old, the patient has a history of about ten years old for both eyes, the eyes break into diseases once the eyes become hot (summer), the eyes are itchy and red, and the eyes are lacrimatory when the eyes are exposed to the wind, and the eyes cannot see the sun, and in severe cases, the eyes are like sand, and white light yellow silk is generated. Doctors have also seen that the Chinese and Western medicines are taken regardless of use. Some doctors say keratitis, seasonal eye disease. After the eye ointment is used for 5 days, the symptoms of itching, redness and tearing in the wind are relieved, and after the eye ointment is continuously used for 10 days, the eye symptoms disappear and do not relapse.
Duzhong, Shandong Dezhou, male, 39 years old, and one year old, glaucoma, which has just begun to be treated with eyedrops, sometimes causes headache and nausea with severe pain, and now the right eye sees things in a white and vast and vague state. The eye ointment of the invention is used for 10 days, the intraocular pressure is reduced, the front of the eye is clear, the head is not painful any more, and the recovery of vision is very obvious.
The eye ointment provided by the invention has the functions of regulating qi, promoting blood circulation, clearing and activating the channels and collaterals, balancing yin and yang, regulating deficiency and excess of internal organs and enhancing the effect of improving eyesight; on the basis of treatment, the massage is matched with manipulation of massage, so that the channels and collaterals can be dredged, the eye muscle fatigue can be relieved, and the regulation function of eyes can be recovered. It can penetrate into eye ground through eye acupoints and eye skin, and has effects of invigorating spleen and stomach, nourishing yin and kidney, promoting hematogenesis and replenishing essence, and invigorating primordial qi. It is used in conjunction with the actions of massaging the acupoints around the eyes to dredge the meridians and restore the eye's regulating function. The eye ointment has obvious treatment effect on the juvenile myopia.
The eye ointment is scientifically formulated according to the compatibility principle of monarch, minister, assistant and guide, various medicines have synergistic effect, and trace elements required by eyes are effectively supplemented by strongly permeating related acupuncture points around the eyes, improving microcirculation of the eyes, increasing blood flow, improving visual excitement, reducing visual threshold, and permeating the eyeground to strengthen spleen and stomach, nourish yin and tonify kidney, engender blood and replenish essence, and supplement primordial qi. Promotes the metabolism of the cornea crystalline lens to recover the elasticity of ciliary muscle, fundamentally recovers the eyesight and is not easy to relapse.
The eye ointment provided by the invention has the advantages of few raw material types, simple preparation process, low cost and no toxic or side effect on human bodies.
The eye ointment provided by the invention adopts a method of smearing, pressing and massaging, can greatly improve the treatment effect, improve the vision of a patient, also avoids other eye diseases of the patient, and has fewer side effects.
Clinical application proves that the eye ointment has curative effects on common eye diseases such as myopia, presbyopia, keratitis, dryness, fundus congestion and the like, and the total effective rate is more than 93%; the effective rate for treating epiphora induced by wind, muscae volitantes, keratitis, dryness and congestion of eyeground is above 95%, and the disease does not recur after healing.
Claims (9)
1. An ophthalmic ointment, which is characterized in that: the raw materials comprise medicinal materials and matrix, wherein the medicinal materials comprise semen Cassiae, flos Chrysanthemi, Margarita powder, Moschus, Galamina, Mentholum, Borneolum Syntheticum, stigma croci Sativi and flos Jasmini sambac essential oil; the matrix comprises lanolin and yellow vaseline; the weight ratio of the raw materials is cassia seed: chrysanthemum: pearl powder: musk: calamine: menthol: borneol: saffron: and (3) jasmine essential oil: lanolin: yellow petrolatum = 20-50: 20-50: 15-30: 5-8: 30-60: 3-5: 1-2: 10-15: 5-10: 100-250: 250-500.
2. The eye ointment of claim 1 wherein: the weight ratio of the raw materials is cassia seed: chrysanthemum: pearl powder: musk: calamine: menthol: borneol: saffron and jasmine essential oil: lanolin: yellow petrolatum = 30: 30: 20: 5: 50: 5: 1: 10: 5: 100: 250.
3. the eye ointment of claim 1 wherein: the weight ratio of the raw materials is cassia seed: chrysanthemum: pearl powder: musk: calamine: menthol: borneol: saffron and jasmine essential oil: lanolin: yellow petrolatum = 50: 20: 30: 6: 60: 3: 2: 15: 10: 250: 500.
4. the eye ointment of claim 1 wherein: the weight ratio of the raw materials is cassia seed: chrysanthemum: pearl powder: musk: calamine: menthol: borneol: saffron and jasmine essential oil: lanolin: yellow petrolatum = 20: 50: 15: 8: 30: 4: 1.5: 13: 7: 200: 350.
5. a method of preparing an eye ointment according to any one of claims 1 to 4, characterized in that: the method comprises the following steps:
A. removing impurities from semen Cassiae, flos Chrysanthemi, Margarita powder, Moschus, Galamina, and stigma croci Sativi, oven drying, pulverizing semen Cassiae, flos Chrysanthemi, Galamina and stigma croci Sativi, sieving, and making into medicinal bag, pulverizing Moschus separately, and sieving;
B. soaking the medicated bag in water, decocting, and collecting the supernatant;
C. heating yellow vaseline and lanolin in a container, melting, filtering, and sterilizing to obtain matrix;
D. dissolving menthol and radix Gentianae with alcohol, adding dissolved menthol and radix Gentianae into the matrix, and mixing;
E. adding Moschus, Margarita powder, flos Jasmini sambac essential oil and supernatant into the matrix in sequence, and mixing.
6. The method for preparing an eye ointment according to claim 5, which comprises: in the step A, the sieving is performed by a 120-mesh sieve.
7. The method for preparing an eye ointment according to claim 5, which comprises: in the step B, the weight of water used for soaking the medicine package is 2 times of the weight of the medicine package, the medicine package is soaked in the water for 10-15 minutes, and the decoction is carried out for 30-60 minutes.
8. The method for preparing an eye ointment according to claim 5, which comprises: in the step C, the heating temperature of the yellow vaseline and the lanolin is 60-80 ℃; the filtration is carried out by using a sieve with 120-150 meshes; the sterilization is carried out by heating in a closed space at 155-165 ℃ for 1 hour.
9. The method for preparing an eye ointment according to claim 8, which comprises: and D, when the matrix is cooled to 50 ℃, pouring the dissolved menthol and borneol into the matrix for mixing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911281566.5A CN110859895A (en) | 2019-12-13 | 2019-12-13 | Eye ointment and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911281566.5A CN110859895A (en) | 2019-12-13 | 2019-12-13 | Eye ointment and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110859895A true CN110859895A (en) | 2020-03-06 |
Family
ID=69659617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911281566.5A Pending CN110859895A (en) | 2019-12-13 | 2019-12-13 | Eye ointment and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110859895A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113713052A (en) * | 2021-09-16 | 2021-11-30 | 天津儒益康中医药科技有限公司 | Eyeball bright eye conditioning nutrient solution cream and preparation method thereof |
| CN115252705A (en) * | 2022-06-27 | 2022-11-01 | 程平 | An eye ointment containing flos Chrysanthemi Indici and its preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101884649A (en) * | 2010-06-30 | 2010-11-17 | 许凤喜 | Traditional Chinese medicine for treating oculopathy |
| CN102716278A (en) * | 2012-05-31 | 2012-10-10 | 苏学军 | Eye ointment for improving eyesight |
-
2019
- 2019-12-13 CN CN201911281566.5A patent/CN110859895A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101884649A (en) * | 2010-06-30 | 2010-11-17 | 许凤喜 | Traditional Chinese medicine for treating oculopathy |
| CN102716278A (en) * | 2012-05-31 | 2012-10-10 | 苏学军 | Eye ointment for improving eyesight |
Non-Patent Citations (2)
| Title |
|---|
| 张智银: "穴位贴压治疗儿童弱视44例", 《河南中医》 * |
| 韩月芝，等: "气相色谱法测定拨云散眼药中冰片的含量", 《现代中西医结合杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113713052A (en) * | 2021-09-16 | 2021-11-30 | 天津儒益康中医药科技有限公司 | Eyeball bright eye conditioning nutrient solution cream and preparation method thereof |
| CN115252705A (en) * | 2022-06-27 | 2022-11-01 | 程平 | An eye ointment containing flos Chrysanthemi Indici and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102139038A (en) | Chinese herbal preparation for treating eye diseases | |
| CN106901896A (en) | A kind of detoxifying health-care eyeshade | |
| CN110859895A (en) | Eye ointment and preparation method thereof | |
| CN103446408B (en) | Traditional Chinese medicine for treating myopia | |
| CN102949523A (en) | Medicinal composition used for relieving visual fatigue and preparation method of capsules thereof | |
| CN101167884B (en) | Orally-administered traditional Chinese medicinal formula for treating cataract | |
| CN101953989A (en) | Electromagnetic wave vision rehabilitation instrument and Chinese medicinal composition | |
| CN102319323B (en) | Eyedrop for reducing intraocular pressure and treating glaucoma and preparation method thereof | |
| CN103463218A (en) | Traditional Chinese medicine preparation for treating tinnitus | |
| CN103520649B (en) | The Chinese medicine for the treatment of facial neuritis | |
| CN105125630A (en) | Eye drops and preparation method thereof | |
| CN102755549B (en) | Drug for curing cataract and preparation method thereof | |
| CN101953990A (en) | Dynawave visual rehabilitation instrument and traditional Chinese medicine compound | |
| CN104306546A (en) | A traditional Chinese medicine composition used for treating optic atrophy, and decoctions, pills and powder of the composition | |
| CN108815390A (en) | A kind of Chinese medicine composition and preparation method thereof improving eyesight | |
| CN105796749B (en) | A kind of traditional Chinese medicine composition for relieving asthenopia | |
| CN104587076A (en) | Traditional Chinese medicine lotion for treating conjunctivitis | |
| CN104706852A (en) | External traditional Chinese medicine composition capable of improving eyesight, preparation method and applications thereof | |
| CN108498615A (en) | A kind of Chinese herb medicine eye health-care patch and preparation method thereof improving eyes based on nitric oxide principle | |
| CN1062164C (en) | Oral medicine pill for curing myopia and amblyopia | |
| CN115089633B (en) | Composition for preventing and treating myopia, eye mask and preparation method | |
| CN102626503B (en) | Chinese medicinal oral liquid for smoothing heart and enhancing intelligence | |
| CN106853207B (en) | Traditional Chinese medicine composition for treating juvenile myopia and preparation method thereof | |
| CN1062165C (en) | Medicinal cream for curing myopia and weak visual acuity | |
| CN106177446B (en) | It is a kind of for treating the Chinese materia medica preparation of bell paralysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200306 |
|
| RJ01 | Rejection of invention patent application after publication |